Company Filing History:
2 out of 231 
1 out of 15 
1 out of 1 Years Active: 2013-2014
Title: Innovations in Allergy Treatment: The Patents of David Ronald Garrod
Introduction
David Ronald Garrod is a distinguished inventor based in Manchester, GB, renowned for his contributions to the field of therapeutic compounds. With a total of two patents to his name, Garrod's work primarily focuses on innovations aimed at combating allergens, particularly those triggered by dust mites. His inventions reflect a significant advancement in allergy treatment and management.
Latest Patents
Garrod's most recent patents revolve around pyruvamide compounds designed as inhibitors of dust mite Group 1 peptidase allergens. These compounds have been specifically created to target allergens such as Der p 1, Der f 1, and Eur m 1. The inventions emphasize both the structural formula of these pyruvamide compounds and their applications in pharmaceutical compositions. They aim to offer therapeutic solutions for conditions such as asthma, rhinitis, allergic conjunctivitis, atopic dermatitis, and canine atopy, thus managing disorders that are exacerbated by dust mite allergens.
Career Highlights
Throughout his career, David Ronald Garrod has made significant strides in research and development. He has been affiliated with notable institutions, including The University of Manchester and St Georges Hospital Medical School, where he has furthered his research in allergy therapeutics. His extensive work in this field has contributed to the understanding of allergens and the development of effective treatments.
Collaborations
Garrod has collaborated with esteemed colleagues such as Clive Robinson and Jihui Zhang, whose collective expertise has enhanced the scope and impact of his research. These collaborations have played a crucial role in advancing the development and application of his patented compounds.
Conclusion
David Ronald Garrod represents a crucial figure in the ongoing fight against allergies, empowered by his innovative patents and collaborative spirit. His work continues to pave the way for breakthroughs in allergy treatment, illustrating the importance of innovation in improving health outcomes for individuals affected by allergic conditions.